医药企业与医师关系的法律规制  

Regulation of physician-industry relationships

作　　者：刘鑫[1] 

机构地区：[1]中国政法大学证据科学研究院,北京100088

出　　处：《中国现代药物应用》2007年第3期1-6,共6页Chinese Journal of Modern Drug Application

基　　金：教育部社科研究基金规划项目(项目编号:06JA820044)

摘　　要：目的为了探讨和研究我国目前医药企业与医师之间的关系,寻求规范两者之间关系向健康正常的方向发展的法律制度。方法复习文献,了解国外的做法和相关法律规定;分析我国医药企业和医师关系的现状,找出问题的根源,提出解决的办法。结果目前我国医药企业与医师的关系非常不健康,国内相关领域法律缺乏,政府监管不到位,药品回扣现象严重。结论从4个方面加以规制:建立起健康的医药销售市场;规范医药企业的商业行为;国家加大医疗投入,取消以药养医的医疗模式;加强医师执业监管。Objective To explore the physician-industry relationships and seek the law and system that was the advancement of its.Methods Author reviews literatures,realizes foreign legislation and modus operandi,and analyses the national conditions of China,finds out source of problems and resolvent.Results The physician-industry relationships of China is very ill-conditioned,being short of law,absence of intendance of government,backhander of prescription.Conclusion To reinforce lawmaking:bulding canonical leechdom market,increasing financial investment,strengthen manage of doctors.

关 键 词：药企与医师的关系 医药市场 回扣 法律 

分 类 号：D922.16[政治法律—宪法学与行政法学]